Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

ARWRARWR
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in ARROWHEAD PHARMACEUTICALS IN

GOLDMAN SACHS GROUP INC holds 1.2M shares of ARWR (ARROWHEAD PHARMACEUTICALS IN), worth $93.7M as of 2026-Q2. The position was decreased (-33.9% shares). ARWR represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$93.7M

Current Shares

1.2M

Total Value Change

+$69.4M

Total Shares Change

-144,203

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1.2M
-33.9%
$93.7M0.0%$81.51
0
2026-Q1
Increased
1.7M
+3.7%
$109.1M0.0%$64.10
31
2025-Q4
Decreased
1.7M
-5.4%
$111.4M0.0%$67.25
0
2025-Q3
Decreased
1.8M
-16.1%
$61.2M0.0%$33.78
0
2025-Q2
Increased
2.1M
+21.4%
$33.4M0.0%$16.08
35
2025-Q1
Increased
1.7M
+34.6%
$22.2M0.0%$13.82
37
2024-Q4
New
1.3M
-
$24.3M0.0%$18.61
40

Other major holders of ARWR: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used